Thalidomide in plasma cell balanitis refractory to conventional topical treatment*
Read
7344
Timeswas read the article
3000
Total PDF
4344
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2025 11 | 9 | 4 | 13 |
| 2025 10 | 190 | 123 | 313 |
| 2025 9 | 154 | 74 | 228 |
| 2025 8 | 110 | 74 | 184 |
| 2025 7 | 137 | 66 | 203 |
| 2025 6 | 122 | 53 | 175 |
| 2025 5 | 148 | 55 | 203 |
| 2025 4 | 119 | 38 | 157 |
| 2025 3 | 159 | 34 | 193 |
| 2025 2 | 153 | 75 | 228 |
| 2025 1 | 138 | 47 | 185 |
| 2024 12 | 93 | 72 | 165 |
| 2024 11 | 121 | 47 | 168 |
| 2024 10 | 132 | 75 | 207 |
| 2024 9 | 153 | 73 | 226 |
| 2024 8 | 153 | 95 | 248 |
| 2024 7 | 175 | 116 | 291 |
| 2024 6 | 127 | 74 | 201 |
| 2024 5 | 133 | 61 | 194 |
| 2024 4 | 89 | 67 | 156 |
| 2024 3 | 78 | 66 | 144 |
| 2024 2 | 103 | 76 | 179 |
| 2024 1 | 58 | 41 | 99 |
| 2023 12 | 44 | 47 | 91 |
| 2023 11 | 51 | 62 | 113 |
| 2023 10 | 54 | 54 | 108 |
| 2023 9 | 49 | 56 | 105 |
| 2023 8 | 39 | 32 | 71 |
| 2023 7 | 29 | 21 | 50 |
| 2023 6 | 55 | 39 | 94 |
| 2023 5 | 57 | 18 | 75 |
| 2023 4 | 45 | 20 | 65 |
| 2023 3 | 43 | 30 | 73 |
| 2023 2 | 45 | 35 | 80 |
| 2023 1 | 36 | 14 | 50 |
| 2022 12 | 50 | 21 | 71 |
| 2022 11 | 51 | 57 | 108 |
| 2022 10 | 59 | 34 | 93 |
| 2022 9 | 62 | 43 | 105 |
| 2022 8 | 33 | 49 | 82 |
| 2022 7 | 28 | 43 | 71 |
| 2022 6 | 41 | 40 | 81 |
| 2022 5 | 31 | 44 | 75 |
| 2022 4 | 29 | 47 | 76 |
| 2022 3 | 40 | 51 | 91 |
| 2022 2 | 29 | 30 | 59 |
| 2022 1 | 28 | 57 | 85 |
| 2021 12 | 34 | 48 | 82 |
| 2021 11 | 30 | 48 | 78 |
| 2021 10 | 39 | 51 | 90 |
| 2021 9 | 42 | 39 | 81 |
| 2021 8 | 55 | 39 | 94 |
| 2021 7 | 40 | 50 | 90 |
| 2021 6 | 47 | 40 | 87 |
| 2021 5 | 27 | 38 | 65 |
| 2021 4 | 73 | 171 | 244 |
| 2021 3 | 26 | 17 | 43 |
| 2021 2 | 26 | 3 | 29 |
| 2021 1 | 15 | 2 | 17 |
| 2020 12 | 8 | 4 | 12 |
Show all
